5-128084056-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001046.3(SLC12A2):c.102G>A(p.Leu34=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00374 in 1,302,660 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 13 hom. )
Consequence
SLC12A2
NM_001046.3 synonymous
NM_001046.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.513
Genes affected
SLC12A2 (HGNC:10911): (solute carrier family 12 member 2) The protein encoded by this gene mediates sodium and chloride transport and reabsorption. The encoded protein is a membrane protein and is important in maintaining proper ionic balance and cell volume. This protein is phosphorylated in response to DNA damage. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 5-128084056-G-A is Benign according to our data. Variant chr5-128084056-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1659746.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.513 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 13 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A2 | NM_001046.3 | c.102G>A | p.Leu34= | synonymous_variant | 1/27 | ENST00000262461.7 | NP_001037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A2 | ENST00000262461.7 | c.102G>A | p.Leu34= | synonymous_variant | 1/27 | 1 | NM_001046.3 | ENSP00000262461 | P4 | |
SLC12A2 | ENST00000343225.4 | c.102G>A | p.Leu34= | synonymous_variant | 1/26 | 1 | ENSP00000340878 | A2 | ||
SLC12A2 | ENST00000509205.5 | c.102G>A | p.Leu34= | synonymous_variant, NMD_transcript_variant | 1/27 | 1 | ENSP00000427109 | |||
SLC12A2 | ENST00000628403.2 | c.102G>A | p.Leu34= | synonymous_variant | 1/26 | 5 | ENSP00000486323 |
Frequencies
GnomAD3 genomes AF: 0.00242 AC: 367AN: 151766Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
367
AN:
151766
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00139 AC: 20AN: 14338Hom.: 0 AF XY: 0.00102 AC XY: 9AN XY: 8800
GnomAD3 exomes
AF:
AC:
20
AN:
14338
Hom.:
AF XY:
AC XY:
9
AN XY:
8800
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00391 AC: 4501AN: 1150786Hom.: 13 Cov.: 30 AF XY: 0.00397 AC XY: 2217AN XY: 557960
GnomAD4 exome
AF:
AC:
4501
AN:
1150786
Hom.:
Cov.:
30
AF XY:
AC XY:
2217
AN XY:
557960
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00242 AC: 367AN: 151874Hom.: 0 Cov.: 32 AF XY: 0.00210 AC XY: 156AN XY: 74256
GnomAD4 genome
AF:
AC:
367
AN:
151874
Hom.:
Cov.:
32
AF XY:
AC XY:
156
AN XY:
74256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | SLC12A2: BP4, BP7 - |
Kilquist syndrome;C5436768:Hearing loss, autosomal dominant 78;C5436771:Delpire-McNeill syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at